Immunogénicité des biomédicaments : quelles conséquences au cours du traitement de la polyarthrite rhumatoïde ?-Reference-Cited by-同舟云学术

Immunogénicité des biomédicaments : quelles conséquences au cours du traitement de la polyarthrite rhumatoïde ?

Published:2016-05 Issue:5 Volume:37 Page:343-349
ISSN:0248-8663
Container-title:La Revue de Médecine Interne
language:fr
Short-container-title:La Revue de Médecine Interne

Author:

Goupille P.

Publisher

Elsevier BV

Subject

Gastroenterology,Internal Medicine

Reference28 articles.

1. Immunogenicity of recombinant human proteins: causes and consequences;Schellekens;J Neurol,2004

2. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective;Vincent;Ann Rheum Dis,2013

3. The immunogenicity, safety and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis;Dore;Clin Exp Rheumatol,2007

4. A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients;van Schouwenburg;J Immunol Methods,2010

5. Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients;Bloem;J Immunol Methods,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intérêt du dosage des anticorps antimédicaments dans les rhumatismes inflammatoires;L'actualité Rhumatologique 2022;2022

2. : An Overview;Therapeutic Antibodies;2021-09-04

3. Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside;Journal of Pharmaceutical Sciences;2021-07

4. Immunomonitoring du rituximab appliqué aux maladies auto-immunes : une aide pour la pratique clinique ?;La Revue de Médecine Interne;2021-06

5. Inventive step assessment of top selling monoclonal antibodies in Brazil;Expert Opinion on Therapeutic Patents;2021-01-18